Last reviewed · How we verify
Ivy Leaves Cough Liquid
Ivy leaves extract promotes mucus clearance and reduces airway inflammation to relieve cough symptoms.
Ivy leaves extract promotes mucus clearance and reduces airway inflammation to relieve cough symptoms. Used for Cough associated with respiratory tract conditions, Productive cough relief.
At a glance
| Generic name | Ivy Leaves Cough Liquid |
|---|---|
| Sponsor | Engelhard Arzneimittel GmbH & Co.KG |
| Drug class | Herbal expectorant |
| Modality | Small molecule |
| Therapeutic area | Respiratory |
| Phase | FDA-approved |
Mechanism of action
Ivy leaves contain saponins and other active compounds that act as expectorants, helping to thin and mobilize respiratory secretions for easier expectoration. The extract also exhibits anti-inflammatory and spasmolytic properties in the airways, reducing cough reflex sensitivity and bronchial irritation. These combined effects make it useful for symptomatic relief of cough associated with respiratory tract conditions.
Approved indications
- Cough associated with respiratory tract conditions
- Productive cough relief
Common side effects
- Gastrointestinal upset
- Nausea
- Allergic reactions (rare)
Key clinical trials
- CHAO Tos: Codeina, HederA Helix, LevOdropropizina Para la TOS (PHASE4)
- Clinical Trial Evaluate the Cough-relieving and Expectorant Effects of the Health Supplement AZKA Nasal and Throat for Children in Outpatient-treated Pharyngitis (NA)
- RCT to Evaluate the Efficacy and Safety of Ivy Leaves Cough Liquid vs. Placebo in the Treatment of Acute Cough (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Ivy Leaves Cough Liquid CI brief — competitive landscape report
- Ivy Leaves Cough Liquid updates RSS · CI watch RSS
- Engelhard Arzneimittel GmbH & Co.KG portfolio CI